Scientific Advisory Board

 

John Elloway
Dr. Nathan Shapiro M.D.

Vice-Chairman of Research at the Beth Israel Deaconess Medical Center

Nathan’s research, both in the clinical and translational arena, focuses on the diagnosis and treatment of sepsis, and he is currently studying the role of Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis.

Nathan has a Doctorate of Medicine from the Temple University School of Medicine in the US, and a Masters in Public Health from the Harvard School of Public Health.



John Elloway
Dr. Steven M. Opal, M.D. 

Professor of Medicine (Research Scholar Track), Infectious Disease Division at the Warren Alpert Medical School of Brown University; and Chief of the Infectious Disease Division at the Memorial Hospital of Rhode Island

Steven is the Chair of the International Sepsis Forum and serves on the steering committee of The International Endotoxin and Innate Immunity Society. He is a fellow of the Infectious Disease Society of America, and has edited several academic research journals and textbooks in the field of infectious diseases, endotoxin-mediated diseases and septic shock.

His professional interests cover endotoxin, cytokines, molecular signaling pathways, microbial mediators, microbial genetics, and antibiotic resistance – and his laboratory research focuses the pathophysiology of septic shock, including the early events that occur in the host-pathogen interaction with systemic infection. Currently, his primary clinical research focuses on clinical trial design, implementation and analysis from phase I to phase III.



John Elloway
Tom van der Poll 

Professor of Medicine in the Academic Medical Center (AMC), University of Amsterdam, the Netherlands

Board certified in Internal Medicine and Infectious Diseases, Tom van der Poll is Head of the Center of Experimental and Molecular Medicine, as well as Chair of the Division of Infectious Diseases, at AMC. His training includes a postdoctoral research fellowship in Cornell University Medical College in New York and he is a former Fellow of the Royal Dutch Academy of Arts and Sciences.

Tom’s research focuses on the innate immune and procoagulant response during sepsis. He has published more than 450 original articles and over 60 book chapters on this topic. He has also served as a member of Data Safety and Clinical Monitoring Boards on several pivotal phase III sepsis and pneumonia trials evaluating immunomodulatory agents.